1. Home
  2. OBDC vs LNTH Comparison

OBDC vs LNTH Comparison

Compare OBDC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Owl Capital Corporation

OBDC

Blue Owl Capital Corporation

HOLD

Current Price

$11.09

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$105.09

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBDC
LNTH
Founded
2015
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.5B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
OBDC
LNTH
Price
$11.09
$105.09
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
$14.00
$87.00
AVG Volume (30 Days)
3.0M
899.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
13.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.80
Revenue
N/A
$343,374,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$14.19
P/E Ratio
N/A
$58.15
Revenue Growth
N/A
3.62
52 Week Low
$10.52
$47.27
52 Week High
$15.19
$105.03

Technical Indicators

Market Signals
Indicator
OBDC
LNTH
Relative Strength Index (RSI) 47.83 70.89
Support Level $11.00 $93.33
Resistance Level $11.60 N/A
Average True Range (ATR) 0.23 3.34
MACD 0.00 0.11
Stochastic Oscillator 35.71 77.87

Price Performance

Historical Comparison
OBDC
LNTH

About OBDC Blue Owl Capital Corporation

Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: